tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

OptimizeRx raises 2025 sales outlook to $104M-$108M, consensus $103.35M

Raises 2025 EBITDA outlook to $14.5M-$17.5M.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1